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U937 cells have low levels of surface thrombospondin 
(TSP) under control conditions but express higher lev- 
els after treatment for 1 day with 100 n&f phorbol my- 
ristate acetate (PMA). Increased surface expression is 
due, in part, to increased biosynthesis. Untreated U937 
cells do not adhere to TSP-coated plastic culture dishes 
but adhere strongly to TSP after stimulation with 
PMA. Untreated U937 cells also adhere weakly to endo- 
thelial cell monolayers while PMA-treated U937 cells 
attach strongly to monolayers of rat pulmonary artery 
endothelial cells. Endothelial cell adhesion appears to 
be mediated, in part, by TSP since antibodies to TSP 
partially inhibit. c 19Sl Academic Press, Inc. 
INTRODUCTION 
Thrombospondin (TSP) is synthesized by a variety of 
cells in culture [l-6] and serves as an adhesion factor 
for many of the same cells [5, 7-101. Our studies have 
shown a direct relationship between TSP synthesis and 
TSP binding among squamous epithelial cells [5, 7, lo- 
121. This provides a mechanism whereby the endoge- 
nously synthesized TSP may be used in an autocrine 
fashion to promote cell-substrate adhesion. In epithelial 
cells, TSP synthesis is related to the growth cycle. Rap- 
idly proliferating, undifferentiated cells synthesize 
large amounts of TSP while synthesis is decreased 
greatly during differentiation [5, lo]. This is consistent 
with the suggestion that TSP has an important function 
in epithelial growth. In support of this is the finding that 
TSP is localized in uivo to sites where epithelial cells are 
rapidly proliferating (i.e., in the basal cell layer of skin 
and around hair follicles) [ 131. A direct role for TSP in 
smooth muscle cell proliferation [ 14, 151 and fibroblast 
proliferation has also been shown [16]. 
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Past studies have demonstrated that monocytes syn- 
thesize TSP in culture [ 17,181. However, monocytes do 
not actively proliferate in culture and the relationship 
between TSP synthesis and monocyte function is un- 
known. To address this question, we have utilized the 
monocyte-like line U937. This cell line was originally 
derived from a histiocytic lymphoma and expresses 
many of the characteristics of monocytes [19]. U937 
cells can be induced by a variety of agents to differen- 
tiate into cells with characteristics of mature macro- 
phages [20]. We report here that U937 cells produce 
small amounts of TSP when unstimulated but synthe- 
size greatly increased amounts of TSP after treatment 
with phorbol esters. Concomitant with this is up-regula- 
tion of adhesion to TSP as well as to vascular endothe- 
lial cells of rat origin. That TSP produced by U937 cells 
may contribute to their adhesion to endothelial cells is 
suggested by the finding that antibodies to TSP par- 
tially inhibit adhesion to endothelial cell monolayers. 
MATERIALS AND METHODS 
U937 cells. A stock culture was obtained from the American Type 
Culture Collection (Rockville, MD). The cells were grown in suspen- 
sion in RPMI-1640 medium containing 10% fetal bovine serum, 100 
U/ml of penicillin, and 100 ag!ml of streptomycin. Growth was at 
37°C in an atmosphere of 5% CO,/95% air. Cells were subcultured as 
required. 
Endothelial cells. Rat pulmonary artery endothelial cells were 
used in certain experiments. These cells were obtained and character- 
ized as described in a recent report [21]. The rat pulmonary artery 
endothelial cells were cultured using minimal essential medium of 
Eagle with Earle’s salts, nonessential amino acids, 100 U/ml of peni- 
cillin, and 100 ag/ml of streptomycin (MEM) supplemented with 10% 
fetal bovine serum as culture medium. Growth was at 37°C in an 
atmosphere of 5% CO,/95% air. These cells were used in experiments 
at passage 20-30. 
Reagents. TSP, rabbit polyclonal antibodies to TSP, and a mouse 
monoclonal antibody to TSP were used in this study. TSP was puri- 
fied from the supernatant fluid of thrombin-activated human plate- 
lets by heparin-Sepharose chromatography as described previously 
[22]. The purified TSP migrated as a single protein band with an 
apparent molecular weight of 160-170 kDa when examined by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
under reducing conditions. The rabbit polyclonal antibodies against 
TSP were purified by affinity chromatography on protein A-Sepha- 
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rose. Specificity for TSP was confirmed by enzyme-linked immuno- 
sorbant assay (ELISA). The mouse monoclonal antibody, designated 
as A6.1 (IgGl) was obtained as an ascites fluid. Characteristics of this 
monoclonal antibody have been described in a previous report [23]. It 
is known to react with an epitope located in the 70.kDa core of the 
TSP molecule. 
Fibronectin, laminin, and rabbit polyclonal antibodies to fibronec- 
tin and laminin were also used in this study. Fibronectin and anti-h- 
bronectin were obtained from Telios Pharmaceutical Co. (San Diego, 
CA). Laminin was obtained from Collaborative Research (Boston, 
MA), and anti-laminin was prepared in our laboratory and character- 
ized as described previously [24]. Each antibody reacted with its re- 
spective ligand in ELISA but showed no cross-reactivity with the 
other ligand or with TSP. Normal mouse IgGl was used as a negative 
control and a mouse monoclonal antibody to the CD18 component of 
the CDllb/CD18 family was used as a positive control in the endothe- 
lial cell adhesion studies. This antibody (Clone IB4) was a generous 
gift from Dr. Sam Wright (Rockefeller University) [25]. OKM-5 anti- 
body was obtained from Ortho Pharmaceutical Co. (Raritan, NJ). 
Phorbol myristate acetate (PMA) was obtained from Sigma Chemi 
cal Co. (St. Louis, MO). 
Biosynthetic labeling. U937 cells were plated in quadruplicate 100. 
mm (diameter) petri dishes at 1 X lo7 cells/dish and incubated for 1 
day as control cells or in the presence of 100 nM PMA. The cells were 
then washed and incubated for 30 min in methionine-free, serum- 
free, minimal essential medium (Flow Laboratories, Gaithersburg, 
MD). The cells were again washed and incubated for an additional 
hour in the same medium containing 100 pCi/dish [?S]methionine 
(1000-1400 mCi/mmol) (NEN, Boston, MA). After the 60-min biosyn- 
thetic pulse, the cells in one control dish and one PMA-treated dish 
were washed and lysed as described below. The cells in the other two 
dishes were washed and incubated for a further 4 h in complete me- 
dium. The l-h pulsed cells were lysed in a solution of phosphate-buf- 
fered saline (PBS) containing three detergents (1% Triton X-100, 
0.5% sodium deoxycholate, and 0.1% SDS; all obtained from Sigma) 
and protease inhibitors including 20 mM EDTA, 5 mM N-ethylmalei- 
mide, 2 mM phenylmethylsulfonyl fluoride (PMSF), and 10 kl/lO ml 
of a protease inhibitor cocktail containing leupeptin 1 mg/ml, anti- 
pain 1 mg/ml, benzamidine 10 mg/ml, and pepstatin 1 mg/ml, as de- 
scribed by Ronnett et al. [26] in studies on the insulin receptor. All of 
the protease inhibitors were obtained from Sigma. The 4-h chase me- 
dia were also supplemented with the detergentjprotease inhibitor 
mixture by adding a one quarter volume of a fivefold concentrated 
solution. The cell lysates and chase media were frozen at -8O”C, 
thawed, and clarified by ultracentrifugation (37,OOOg for 60 min). Im- 
munoreactive TSP was precipitated with a 1:lOO dilution of the rabbit 
anti-TSP and protein A-Sepharose (Sigma) according to the protocol 
of Ruddon et al. [27]. The washedimmunoprecipitates were divided in 
half and eluted with boiling (5 min) in twofold-concentrated mercap- 
toethanol. The immunoprecipitated material was fractionated on a 
5% polyacrylamide gel employing the Laemmli system [28]. Radioac- 
tive bands were visualized by autoradiography with En3Hance 
(NEN), exposing the dried gels to X-ray film (Kodak XAR-2) for 2 
days, In some experiments, anti-fibronectin was used in place of anti- 
TSP. The immunoprecipitation was carried out in exactly the same 
manner. 
Enzyme-linked immunosorbent assay (ELISA). ELISAs were per- 
formed to quantify the amount of TSP secreted into the culture me- 
dium by control and PMA-treated cells. Cells were plated at 3.5 X lo5 
cells per well in growth medium with or without PMA and incubated 
for 1 day. Following this, the cells were washed twice in serum-free 
RPMI-1640 medium and incubated for an additional 18 h in RPMI- 
1640 medium supplemented with 200 fig/ml BSA (RPMI-BSA). The 
18-h culture medium was then harvested, clarified by low-speed cen- 
trifugation, and added to wells of a 96.well plate (Falcon Plastics, 
Oxnard, CA) from lots that had been prescreened for acceptability in 
ELISAs. We used 200 ~1 per well and incubated the wells for 4 h at 
37°C. RPMIIBSA served as a negative control. Purified human plate- 
let TSP (0.5-0.0005 pg per well) was also added to the assay plate in 
the same buffer to serve as a standard. After the 4-h incubation, the 
culture medium from the cells and the control culture medium were 
removed from the wells and the ELISA was run exactly as described 
previously [29]. The cells from which the culture medium was ob- 
tained were harvested with trypsin and counted. In some assays, anti- 
fibronectin was used in place of anti-TSP. 
Immuno~uorescence. Control and PMA-treated cells were exam- 
ined for anti-TSP binding by indirect immunofluorescence 1 day 
after treatment. At the time of staining, the culture medium was re- 
moved and the cells were gently washed three times in cold PBS. All 
subsequent steps were carried out at 4°C. The cells were stained ini- 
tially with a 1:20 dilution of the rabbit anti-TSP or normal rabbit 
serum (45 min) and then washed three times. They were then stained 
with a 1:50 dilution of Auorescein-conjugated swine anti-rabbit IgG 
(45 min) obtained from Accurate Scientific and Chemical (Westbury, 
NY). Following three additional rinses in PBS, the coverslips were 
placed on glass slides and viewed immediately by standard fluores- 
cence microscopic techniques. 
Adhesion assay. U937 cell adhesion to purified extracellular ma- 
t,rix components (e.g., TSP, fibronectin, and laminin) and to endothe- 
lial cell monolayers was examined in this study. Matrix-coated plastic 
culture dishes were prepared by adding 20 fig of the desired protein to 
each well of a 24.well dish in 0.5 ml of MEM and incubating the dish 
for 2 h at 37°C. Following this, the nonattached protein was removed 
and the dishes were incubated for 30 min with 0.5 ml of MEM con- 
taining 10 mg/ml of bovine serum albumin. Control U937 cells and 
cells that had been treated with 100 nA4 PMA for an appropriate 
period of time (normally 1 day) were harvested from culture, washed 
two times in MEM containing 200 fig/ml of bovine serum albumin 
(MEM-BSA), and added to the washed wells at 5 x lo5 cells/well. At 
various times later, the nonattached cells were removed and the wells 
were washed in MEM-BSA. The attached cells were removed with 
0.25% trypsin and counted. 
To assess adhesion to endothelial cells, wells of a 24.well dish were 
seeded with 1 X lo” cells/well in growth medium and incubated over- 
night. The next day, the culture medium was removed from the mono- 
layers and the cells were washed two times with warm MEM-BSA. 
Control and PMA-treated U937 cells were prepared as described 
above except that during the final day of incubation, 1 PCi of 
Na,“CrO, per 1 X lo6 cells was included in the culture medium. The 
“‘Cr-labeled U937 cells were added to the endothelial cell monolayers 
at 5 X lo5 cells per well in MEM-BSA. At various times later, the 
nonattached cells were removed and the monolayers were washed 
gently two times with warm MEM-BSA. After the final wash, the 
wells were trypsinized and the entire content of the well counted in a 
y-scintillation counter. The total counts per minute (CPM) recovered 
from each well was compared to the number of CPM originally added 
to determine the percentage of adherent cells. 
RESULTS 
TSPproduction by control and PMA-stimulated U937 
cells. In the first series of experiments control U937 
cells and U937 cells incubated for 1 day with 100 nM 
PMA in growth medium were examined for TSP produc- 
tion, secretion, and cell surface expression. Results 
from biosynthetic labeling/immunoprecipitation stud- 
ies are shown in Fig. 1. Whole cell extract and culture 
fluid from control cells are shown in lanes 1 and 3. 
Whole cell extract and culture fluid from the PMA- 
treated cells are shown in lanes 2 and 4. A faint band can 
be seen at the 160- to 170-kDa locus in lane 1, consistent 
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FIG. 1. Analysis by SDSPAGE of TSP immunoprecipitates 
from biosynthetically labeled U937 cells. Cell lysates from control 
and PMA-treated U937 cells immunoprecipitated with anti-TSP are 
shown in lanes 1 and 2, respectively. Chase media from the same cells 
immunoprecipitated with anti-TSP are shown in lanes 3 and 4, respec- 
tively. 
with the molecular weight of TSP under reducing condi- 
tions. The corresponding band in lane 2 is much more 
intense. The culture fluid from the control cells, lane 3, 
shows no detectable immunoprecipitate with antibody 
to TSP. In contrast, the culture fluid from the PMA- 
treated cells (lane 4) shows two major anti-TSP-precipi- 
table moieties. These two moieties have molecular 
weights of approximately 120 and 70 kDa, based on com- 
parison of their migration with molecular weight 
markers. No detectable band corresponding to intact 
TSP (i.e., at 160-170 kDa under reducing conditions) 
was seen. The presence of moieties at 120 and 70 kDa is 
consistent with proteolysis of intact TSP. TSP is a pro- 
teolytically sensitive molecule and fragments of I20 and 
70 kDa are the major products seen after limited pro- 
teolysis [lo]. 
Extracts from control and PMA-stimulated U937 
cells were also immunoprecipitated with rabbit polyclo- 
nal anti-fibronectin. There was no detectable band in 
the 220- to 240-kDa region of the gel prepared with con- 
trol cell extract or with extract from PMA-treated cells 
1 day after treatment (not shown). 
ELISAs were used to confirm the increased release of 
anti-TSP reactive moieties from PMA-treated U937 
cells. For these experiments, U937 cells were cultured 
for 1 day in growth medium with or without PMA. Fol- 
lowing this, they were washed and incubated for 18 h in 
RPMI-BSA. These culture fluids were then harvested 
and assayed for TSP and fibronectin by ELISA. The 
amount, of TSP detected in the culture fluid from the 
PMA-treated cells was much higher than the amount 
detected in the control culture fluid (Table 1). In con- 
trast, there was no measurable amount of fibronectin in 
the culture fluid from either control or PMA-treated 
Indirect immunofluorescence studies with anti-TSP 
were carried out to determine if there was also increased 
cell surface TSP expression following PMA treatment. 
Anti-TSP-stained control cells and cells treated for 1 
day with PMA are shown in Fig. 2. There was signifi- 
cantly more staining of the treated cells than control 
cells. This was not seen when normal rabbit serum or 
anti-fibronectin was used in place of anti-TSP (not 
shown). 
U937 cell adhesion to purified extracellular matrix 
components. Control and PMA-treated U937 cells 
were examined for attachment to immobilized TSP, fi- 
bronectin, and laminin. A small percentage of untreated 
cells attached to fibronectin but virtually none attached 
to TSP or laminin (Fig. 3). One day after treatment with 
100 nM PMA, the U937 cells demonstrated dramati- 
cally increased attachment to both TSP and fibronectin 
(Fig. 3). In the case of fibronectin, a significant percent- 
age (20-30%) of the attached cells also spread. There 
was no spreading on TSP and the cells formed large 
clumps on this substrate (not shown). In contrast to the 
results with TSP and fibronectin, PMA-treated U937 
cells did not attach on laminin (Fig. 3). The adhesion 
response to TSP was specific in that pretreatment of 
the substrate with 50 /*g of rabbit polyclonal anti-TSP 
completely inhibited the interaction. The same anti- 
body had no effect on cell attachment to fibronectin 
while rabbit polyclonal anti-fibronectin did not inter- 
fere with the attachment to TSP. We were also unable 
to block adhesion to TSP with commercially available 
OKM-5 monoclonal antibody (incubated with the cells 
for 15 min prior to addition of the cells to the substrate). 
U937 cell adhesion to endothelial cells. Control and 
PMA-stimulated U937 cells were examined for adhe- 
sion to rat pulmonary artery endothelial cells. Very few 
of the untreated U937 cells (between 4-18%, depending 
TABLE 1 
Immunoreactive TSP and Fibronectin in Culture Fluid 
from Control and PMA-treated IJ937 Cells 
Amount produced (ng/lOO ~1) 
Treatment 
grow TSP Fibronectin 
Control <5 <5 
PMA-treated 25 f 3 <5 
Note. Control U937 cells and PMA-treated U937 cells (1 x 106/ml) 
were incubated in RPMI-1640 medium containing 10% fetal bovine 
serum for 1 day. The cells were then washed two times and incubated 
in RPMI-BSA for 18 h. The 18-h culture fluids were harvested and 
analyzed for TSP and fibronect,in by ELISA. Values were obtained 
directly from standard curves. Values shown represent averages Idif- 
ferences between individual values and averages based on duplicate 
samples in a single experiment. The experiment was repeated five 
times with similar results. U937 cells (Table 1). 
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FIG. 2. Immunofluorescence staining of control (a) and PMA-treated 17937 cells (h) with anti-TSP in the viable state. Photographs a a-e 1 
min exposures. X400. 
on the experiment) attached to the endothelial cells. In 
contrast, a large percentage of the PMA-stimulated 
U937 cells attached to the endothelial cell monolayers. 
Attachment was seen as early as 30 min after plating 
and was maximal by 4 h. In order to determine if TSP 
plays a role in U937 cell adhesion to endothelial cells, 
mouse monoclonal antibodies to TSP were used in 
blocking experiments. For these experiments, control 
and PMA-treated U937 cells were harvested from cul- 
ture, washed, and incubated with the appropriate anti- 
body for 15 min in assay buffer (MEM-BSA). The cells 
along with the antibodies were then added to the endo- 
thelial cell monolayers and the assay carried out in the 
normal manner. The monoclonal antibody to TSP sig- 
nificantly inhibited attachment of PMA-treated U937 
cells as compared to the negative control antibody (Ta- 
ble 2). However, anti-TSP proved to be much less effec- 
tive than the antibody directed against CD18 (Table 2). 
DISCUSSION 
TSP production by monocytes has been examined in 
two previous studies. In the first, Jaffe et al. [17] demon- 
strated that human peripheral blood monocytes and 
mouse resident peritoneal macrophages synthesized 
TSP and secreted the synthesized moiety into the cul- 
ture medium. Most of the secreted TSP appeared to be 
intact, as indicated by autoradiography of biosyntheti- 
tally labeled/immunoprecipitated extracts. It was re- 
ported in this study that TSP could not be detected on 
the cell surface or in the cell layer by immunofluores- 
cence. In a later study we also showed that human mono- 
cytes synthesize TSP and secrete the intact molecule 
into the culture medium [18]. Consistent with the ob- 
servations of Jaffe et al. [ 171, we did not see cell surface 
TSP by immunofluorescence when the cells were exam- 
ined immediately after plating. However, when the cells 
were examined after they had been in culture for 18 h 
cell surface staining for TSP was clearly evident. Our 
study also suggested that TSP may serve in the interac- 
tion of human peripheral blood monocytes with human 
squamous carcinoma cells. This was based on the obser- 
vation that antibodies to TSP partially inhibited mono- 
cyte killing of human squamous carcinoma cells and on 
the observation that squamous epithelial cells which 
expressed high levels of TSP receptors were more 
sensitive to killing by monocytes than cells which did 
not [18]. 
In the present study we examined TSP production 
and cell surface expression by U937 cells. The U937 line 
was originally derived from a histiocytic lymphoma and 
demonstrates characteristics of monocytes [19]. U937 
cells can be induced by a variety of agents, including 
PMA, to differentiate into mature macrophage-like 
cells [20]. Consistent with previous findings with hu- 
man peripheral blood monocytes, which did not express 
surface TSP immediately upon isolation but which did 
after incubation in vitro for 18 h [17, 181, unstimulated 
U937 cells were deficient in surface TSP but stained 
brightly with anti-TSP after treatment with PMA. With 
both normal peripheral blood monocytes and U937 
cells, therefore, TSP expression is correlated with cell- 
substrate adhesion in vitro. It should be noted that 
mouse resident peritoneal macrophages have also been 
shown to synthesize TSP [17]. Thus, TSP production 
appears to reflect transition from the monocytoid state 
to macrophage-like cells. 
In addition to stimulating TSP biosynthesis, PMA 
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FIG. 3. Attachment of control and PMA-treated US37 cells to 
plastic culture dishes coated with 20 cg of TSP, fihronectin, and la- 
minin. Values shown represent the average percentage of cells at- 
tached to matrix-coated dishes -+ differences between individual val- 
ues and averages based on duplicate samples in a single experiment. 
The experiment was repeated three times with similar results. 
treatment of U937 cells also resulted in increased adhe- 
sion to TSP. This suggests that TSP receptor expres- 
sion is up-regulated concomitantly with induction of 
TSP synthesis. Coordinated induction of TSP biosyn- 
thesis and TSP binding is not unique to these cells. The 
induction of TSP synthesis in squamous epithelial cells 
is also accompanied by increased TSP binding and in- 
creased cell-substrate adhesion [ll, 121. Additionally, 
past studies have shown that with other extracellular 
matrix molecules such as fibronectin, induction of li- 
gand synthesis is accompanied by up-regulation of re- 
ceptor expression [30-321. Thus, coregulation of extra- 
cellular matrix synthesis and expression of their cell 
surface receptors may be a common occurance. At pres- 
ent, the nature of the TSP-binding moieties up-regu- 
lated on the U937 cells by PMA is not known. At least 
one moiety which has been reported to serve as a TSP 
receptor on monocytes (i.e., CD36, the antigen for com- 
mercially available OKM5 monoclonal antibody) [33] is 
also expressed on U937 cells [33] and has been reported 
to be up-regulated following PMA treatment [34]. Per- 
haps increased expression of this moiety accounts for 
the increased adhesiveness that follows PMA treat- 
ment. We were unable, however, to demonstrate signifi- 
cant inhibition with antibody directed against this li- 
gand and several additional TSP-binding moieties have 
been identified on other cells. Among these are a 
member of the integrin family [35], a heparan sulfate 
proteoglycan [ 361, and a glycolipid [ 371. Additional stud- 
ies will be necessary to determine if any of these struc- 
tures are also influenced by PMA and if any of these 
receptors are critical to I7937 cell adhesive functions. 
A goal of this work was to determine if TSP plays a 
role in U937 cell adhesion to endothelial cells. Previous 
studies have shown a role for TSP in monocyte-platelet 
interaction [34] and our recent study suggested that 
TSP may be involved in monocyte killing of human 
squamous carcinoma cells [ 181. In the present study we 
used a murine monoclonal antibody to TSP to block 
adhesion to rat pulmonary artery endothelial cells. At- 
tachment of PMA-activated U937 cells to endothelial 
cells in the presence of this antibody was reduced by 
approximately 25%. These data suggest that TSP con- 
tributes to but is not the major surface ligand mediating 
adhesion of activated U937 cells to the endothelium. In 
the same series of experiments as those described 
above, we found that antibodies to TSP also inhibited 
human peripheral blood monocyte adhesion to the rat 
pulmonary artery endothelial cells by approximately 
TABLE 2 
Inhibition of U937 Cell Adhesion to Rat 
Pulmonary Artery Endothelial Cells 








53 -t 1 
41 * 1 
12 -+ 1 
54 i 2 
Note. Control or PMA-treated IJ937 cells were incubated with the 
appropriate antibody (50 ~1 of antibody incubated with 200 ~1 of cell 
suspension) for 15 min and then the cells with antibody were added to 
the endothelial monolayers. Cell attachment was determined 2 h 
later. Values shown represent averages *standard deviations based 
on triplicate samples in a single experiment. The experiment was 
repeated two times with similar results. 
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25% (unpublished observation). Thus, TSP may play a 16. Phan, S. H., Dillon, R. G., McGarry, B. M., and Dixit, V. M. 
(1989) Biochem. Biophys. Res. Commun. 163, 56. 
Jaffe, E. A., Ruggiero, J. T., and Falcone, D. J. (1985) Blood 65, 
79. 
role in the adhesive interactions of normal monocyte as 
well as U937 cells with the endothelium. 17. 
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